Blue Cohosh (Caulophyllum thalictroides)

Blue cohosh (Caulophyllum thalictroides) contains alkaloids including methylcytisine and magnoflorine that may stimulate uterine contractions. This Native American herb has been traditionally used by midwives for labor support, though clinical evidence remains limited.

Origin & History

Blue cohosh (Caulophyllum thalictroides) is a perennial herb native to eastern North America, belonging to the Berberidaceae family, with its rhizome and roots used medicinally. Extracts are typically prepared from dried roots using methanol or water-based methods, containing alkaloids and saponins as primary chemical classes.

Historical & Cultural Context

Blue cohosh has been used in Native American traditional medicine for centuries to induce labor, treat uterine conditions, and as an emmenagogue. Midwives historically employed root extracts for childbirth facilitation, though safety remains unverified.

Health Benefits

• Labor induction support - Traditional use by midwives, though no human clinical trials exist
• Uterine stimulation - Historical application for childbirth facilitation, safety unverified
• Emmenagogue properties - Traditional Native American use for menstrual regulation, no clinical evidence
• WARNING: Teratogenic effects demonstrated in preclinical models at 10 μg/mL
• CAUTION: No human safety or efficacy data available from controlled trials

How It Works

Blue cohosh alkaloids, particularly methylcytisine and magnoflorine, may interact with nicotinic acetylcholine receptors and potentially stimulate smooth muscle contractions in uterine tissue. The saponins caulosaponin and cauloside may contribute to increased uterine tone through calcium channel modulation. However, the exact molecular pathways remain poorly understood due to limited research.

Scientific Research

No human randomized controlled trials, clinical trials, or meta-analyses specifically on blue cohosh were identified. Preclinical evidence includes a medaka embryo study showing severe teratogenic effects on cardiovascular and craniofacial development. A systematic review concluded insufficient human safety data and urged cohort studies among midwives using it for labor induction.

Clinical Summary

No randomized controlled trials have evaluated blue cohosh's safety or efficacy in humans. Case reports and observational studies have documented both traditional use patterns and potential adverse effects. A few retrospective studies examining birth outcomes showed mixed results regarding labor duration and complications. The lack of standardized preparations and dosing protocols has hindered quality clinical research.

Nutritional Profile

Blue Cohosh (Caulophyllum thalictroides) is not consumed as a food source and thus lacks conventional macronutrient or micronutrient significance. Its profile is dominated by pharmacologically active bioactive compounds rather than nutritional constituents. Primary alkaloids include caulosaponin (a quinolizidine alkaloid) and caulophylline (N-methylcytisine), the latter present at approximately 0.01–0.05% dry weight of root material, which acts as a nicotinic acetylcholine receptor agonist and is largely responsible for cardiovascular and uterotonic toxicity. Baptifoline and anagyrine (additional quinolizidine alkaloids) are present at trace concentrations (<0.01% dry weight) and contribute to teratogenic risk documented in preclinical models. Steroidal saponins, particularly caulosaponin and related glycosides, occur at approximately 0.5–2.0% dry weight of rhizome and root, and are understood to drive uterine smooth muscle stimulation via oxytocin-like receptor interactions. Taspine, a benzylisoquinoline alkaloid, is present in small quantities and has demonstrated vasoactive properties in vitro. Resins constitute roughly 2–5% of dry root weight. Phytosterols including beta-sitosterol are present at low concentrations. Mineral content includes trace amounts of calcium, magnesium, and potassium, but at concentrations nutritionally insignificant given the non-dietary context of use. No meaningful fiber, protein, or lipid fractions are documented for therapeutic preparations. Bioavailability data for human pharmacokinetics is absent from peer-reviewed literature; animal models suggest rapid gastrointestinal absorption of alkaloid fractions with hepatic first-pass metabolism. All concentrations referenced derive from phytochemical analyses of dried rhizome and root preparations.

Preparation & Dosage

No clinically studied dosage ranges for blue cohosh in humans were identified. Preclinical studies used 10 μg/mL methanolic root extract, which showed toxicity. Contraindicated during pregnancy and lactation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Black cohosh, Raspberry leaf, Cramp bark, Wild yam, Dong quai

Safety & Interactions

Blue cohosh may cause serious adverse effects including stroke, heart attack, and seizures due to its alkaloid content. Pregnant women should avoid this herb as it may cause premature labor, fetal distress, or birth defects. The herb may interact with cardiac medications, blood pressure drugs, and other uterine stimulants. FDA has issued warnings about blue cohosh safety concerns.